Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Winter;12(1):20-4.

Complications of pelvic lymphadenectomy: do the risks outweigh the benefits?

Stacy Loeb  1 , Alan W Partin, Edward M Schaeffer
Affiliations

Complications of pelvic lymphadenectomy: do the risks outweigh the benefits?

Stacy Loeb et al. Rev Urol. 2010 Winter.

Abstract

The American Urological Association Best Practice Policy states that although pelvic lymph node dissection (PLND) is commonly done with radical prostatectomy, its morbidity must be considered, particularly in cases in which it offers little additional information. The benefits of PLND include more accurate staging and reassurance for the patient. In addition, PLND may be therapeutic for men with lymph node metastases and may result in long-term biochemical cure for selected node-positive patients. However, the incidence of node positivity is declining, and accordingly a greater number of lymphadenectomies must be performed to benefit 1 patient. In addition to the associated cost, PLND has the potential for morbidity, including lymphoceles, thromboembolic events, ureteral injury, and neurovascular injury. Patients and physicians should therefore assess the risk/benefit ratio associated with PLND on an individual basis to permit informed treatment decisions.

Keywords: Lymph node metastases; Lymphocele; Nerve injury; Pelvic lymph node dissection; Prostate cancer; Radical prostatectomy; Risk to benefit ratio; Thromboembolic events; Ureteral injury; Vascular injury.

PubMed Disclaimer

References

    1. Allaf ME, Palapattu GS, Trock BJ, et al. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol. 2004;172(5 pt 1):1840–1844. - PubMed
    1. Musch M, Klevecka V, Roggenbuck U, Kroepfl D. Complications of pelvic lymphadenectomy in 1,380 patients undergoing radical retropubic prostatectomy between 1993 and 2006. J Urol. 2008;179:923–928. - PubMed
    1. Hövels AM, Heesakkers RA, Adang EM, et al. Cost-analysis of staging methods for lymph nodes in patients with prostate cancer: MRI with a lymph node-specific contrast agent compared to pelvic lymph node dissection or CT. Eur Radiol. 2004;14:1707–1712. - PubMed
    1. Campbell SC, Klein EA, Levin HS, Piedmonte MR. Open pelvic lymph node dissection for prostate cancer: a reassessment. Urology. 1995;46:352–355. - PubMed
    1. Fowler JE , Jr, Whitmore WF., Jr The incidence and extent of pelvic lymph node metastases in apparently localized prostatic cancer. Cancer. 1981;47:2941–2945. - PubMed